Published on 20 Jun 2024 on Simply Wall St. · via Yahoo Finance
Key Insights
Significantly high institutional ownership implies Nurix Therapeutics' stock price is sensitive to their trading actionsThe top 11 shareholders own 51% of the companyOwnership research along with analyst forecasts data help provide a good understanding of opportunities in a stock
Every investor in Nurix Therapeutics, Inc. (NASDAQ:NRIX) should be aware of the most powerful shareholder groups. We can see that institutions own the lion's share in the company with 66% ownership. Put another way, the group faces the maximum upside potential (or downside risk).